Abstract
The present double-blind, placebo-controlled study investigated the effects of intravenous magnesium on heart rate and rate variability in 30 patients with chronic atrial fibrillation. During standardized conditions, intraindividual variation in heart rate and rate variability was low in patients with chronic atrial fibrillation and magnesium had no effect on heart rate or rate variability.
Publication types
-
Clinical Trial
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Atrial Fibrillation / physiopathology*
-
Atrioventricular Node / drug effects
-
Atrioventricular Node / physiopathology
-
Dose-Response Relationship, Drug
-
Double-Blind Method
-
Female
-
Heart Rate / drug effects*
-
Humans
-
Infusions, Intravenous
-
Magnesium / administration & dosage
-
Magnesium / pharmacology*
-
Male